Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingebrigt Sylte

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Journal of Psychopharmacology (Oxford, England)|June 21, 2006
From genomics to drug targetsSvein G Dahl, Ingebrigt Sylte
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2012
Homology modeling of transporter proteins (carriers and ion channels)Aina Westrheim Ravna, Ingebrigt Sylte
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Molecular modelling of drug targets: the past, the present and the futureSvein G Dahl, Ingebrigt Sylte
Chemical Biology & Drug Design|January 21, 2009
The thermolysin family (M4) of enzymes: therapeutic and biotechnological potentialOlayiwola A Adekoya, Ingebrigt Sylte
Current Topics in Medicinal Chemistry|August 12, 2008
Receptor-binding and pharmacokinetic properties of dopaminergic agonistsTrond Kvernmo, John Houben, Ingebrigt Sylte
In Silico Biology|October 3, 2009
Determinants for psychrophilic and thermophilic features of metallopeptidases of the M4 familyMahmud Tareq Hassan Khan, Ingebrigt Sylte
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2023
Homology Modeling of Transporter ProteinsIngebrigt Sylte, Mari Gabrielsen, Kurt Kristiansen
Current Drug Discovery Technologies|November 8, 2007
Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug moleculesMahmud Tareq Hassan Khan, Ingebrigt Sylte
Annals of Medicine|October 10, 2002
Bioinformatics: from genome to drug targetsSvein G Dahl, Kurt Kristiansen, Ingebrigt Sylte
European Journal of Medicinal Chemistry|February 8, 2005
Atypical and typical antipsychotic drug interactions with the dopamine D2 receptorErik Hjerde, Svein G Dahl, Ingebrigt Sylte
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Journal of Psychopharmacology (Oxford, England)|June 21, 2006
From genomics to drug targetsSvein G Dahl, Ingebrigt Sylte
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2012
Homology modeling of transporter proteins (carriers and ion channels)Aina Westrheim Ravna, Ingebrigt Sylte
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Molecular modelling of drug targets: the past, the present and the futureSvein G Dahl, Ingebrigt Sylte
Chemical Biology & Drug Design|January 21, 2009
The thermolysin family (M4) of enzymes: therapeutic and biotechnological potentialOlayiwola A Adekoya, Ingebrigt Sylte
Current Topics in Medicinal Chemistry|August 12, 2008
Receptor-binding and pharmacokinetic properties of dopaminergic agonistsTrond Kvernmo, John Houben, Ingebrigt Sylte
In Silico Biology|October 3, 2009
Determinants for psychrophilic and thermophilic features of metallopeptidases of the M4 familyMahmud Tareq Hassan Khan, Ingebrigt Sylte
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2023
Homology Modeling of Transporter ProteinsIngebrigt Sylte, Mari Gabrielsen, Kurt Kristiansen
Current Drug Discovery Technologies|November 8, 2007
Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug moleculesMahmud Tareq Hassan Khan, Ingebrigt Sylte
Annals of Medicine|October 10, 2002
Bioinformatics: from genome to drug targetsSvein G Dahl, Kurt Kristiansen, Ingebrigt Sylte
European Journal of Medicinal Chemistry|February 8, 2005
Atypical and typical antipsychotic drug interactions with the dopamine D2 receptorErik Hjerde, Svein G Dahl, Ingebrigt Sylte
Pageof 10